Thirty-four novel compounds were synthesized using chesulfamide (N-(2-trifluoromethyl-4-chlorophenyl)-2-oxocyclohexyl sulfonamide), a high-profile fungicide, as the lead compound, and their structures were characterized by H NMR, C NMR, MS and elemental analysis. Additionally, the structure of (1S,2R)-2-((3-bromophenethyl)amino)-N-(4-chloro-2-trifluoromethylphenyl)cyclohexane-1-sulfonamide (IV-9) was confirmed by X-ray single crystal diffraction. The mycelium inhibition tests, spore germination inhibition tests, tomato pot tests and field trials were performed against strains of B. cinerea. Bioassay results showed that most of target compounds had good fungicidal activity against B. cinerea, in particular, IV-9 exhibited similar or superior effects to procymidone, boscalid and pyrisoxazole in all in vitro and in vivo tests. Moreover, there was no positive cross-resistance found between the compound IV-9 and eight commercial fungicides (azoxystrobin, boscalid, chlorothalonil, diethofencarb, fludioxonil, procymidone, pyrimethanil and pyrisoxazole) in the cross-resistance validation test performed by an innovative method.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2019.126859 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The intersection of the HER2-low subtype with endocrine resistance: the role of interconnected signaling pathways.
Front Oncol
November 2024
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
Article Synopsis
- Endocrine therapy targeting the estrogen receptor alpha (ERα) has been successful for treating estrogen receptor positive (ER+) breast cancer since the 1970s, but most patients eventually develop resistance, particularly in metastatic cases.
- Resistance often stems from genetic changes in the estrogen receptor, the MAP kinase pathway, or transcription factors, with mutations in HER2 leading to total resistance against multiple therapies.
- Recent studies suggest a link between endocrine-resistant tumors and the HER2-low subtype, indicating a need for more research into the signaling networks in HER2-low tumors that could be targeted to overcome resistance.
Discovery of Novel Coumarin Pleuromutilin Derivatives as Potent Anti-MRSA Agents.
J Med Chem
December 2024
School of Science, Xihua University, Chengdu 610039, China.
Treating methicillin-resistant (MRSA) infection remains one of the most difficult challenges in clinical practice, primarily due to the resistance of MRSA to multiple antibiotics. Therefore, there is an urgent need to develop novel antibiotics with high efficacy and low cross-resistance rates. In this study, a series of novel pleuromutilin derivatives with coumarin structures were synthesized and subsequently assessed for their biological activities.
View Article and Find Full Text PDFEffects of sulfamethoxazole and copper on the natural microbial community from a fertilized soil.
Appl Microbiol Biotechnol
November 2024
Water Research Institute, National Research Council (IRSA-CNR), Montelibretti, 00010, Rome, Italy.
Cattle manure or its digestate, which often contains antibiotic residues, can be used as an organic fertilizer and copper (Cu) as a fungicide in agriculture. Consequently, both antibiotics and Cu are considered soil contaminants. In this work, microcosms were performed with soil amended with either manure or digestate with Cu and an antibiotic (sulfamethoxazole, SMX) co-presence and the planting of Lactuca sativa.
View Article and Find Full Text PDFOverexpression of the CcCYP51A and CcCYP51B genes confer Corynespora cassiicola resistance to prochloraz.
Pestic Biochem Physiol
November 2024
College of Plant Protection, Shenyang Agricultural University, No. 120 Dongling Road, Shenhe District, Shenyang City 110866, People's Republic of China. Electronic address:
Cucumber Corynespora leaf spot caused by Corynespora cassiicola is the primary disease responsible for reducing cucumber yield, and prochloraz is the main fungicide used to control C. cassiicola. This study investigated the sensitivity and resistance mechanism of C.
View Article and Find Full Text PDFA comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors.
J Pathol
December 2024
Unit of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, Aviano, Italy.
Breast cancer (BC) is marked by significant genetic, morphological and clinical heterogeneity. To capture this heterogeneity and unravel the molecular mechanisms driving tumor progression and drug resistance, we established a comprehensive patient-derived xenograft (PDX) biobank, focusing particularly on luminal (estrogen receptor, ER+) and young premenopausal patients, for whom PDX models are currently scarce. Across all BC subtypes, our efforts resulted in an overall success rate of 17% (26 established PDX lines out of 151 total attempts), specifically 15% in luminal, 12% in human epidermal growth factor receptor 2 positive (HER2+) and 35% in triple negative BC.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!